| Howard W Lynd, MD | |
|
286 Us Highway 23 N, Suite 102, Prestonsburg, KY 41653-8732 | |
| (606) 874-0032 | |
| (606) 874-0064 |
| Full Name | Howard W Lynd |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology - Pain Medicine |
| Location | 286 Us Highway 23 N, Prestonsburg, Kentucky |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851337596 | NPI | - | NPPES |
| 64023070 | Medicaid | KY | |
| K132050 | Other | KY | MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0000X | Pain Medicine - Pain Medicine | 33635 (Kentucky) | Secondary |
| 207LP2900X | Anesthesiology - Pain Medicine | 33635 (Kentucky) | Primary |
| Entity Name | Signify Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689158487 PECOS PAC ID: 3274895263 Enrollment ID: O20210209002652 |
News Archive
Cancer cells have an uncanny ability to evolve and adapt to overcome the treatments used against them. While patient survival has been extended by modern drugs that block the production or action of male hormones that fuel prostate cancer - androgen receptor inhibitors such as enzalutamide, apalutamide, darolutamide, and abiraterone - eventually these drugs stop working.
Scientists at the Johns Hopkins Kimmel Cancer Center say they have preliminary evidence in laboratory-grown, human airway cells that a condensed form of cigarette smoke triggers so-called "epigenetic" changes in the cells consistent with the earliest steps toward lung cancer development.
A new stem cell-based approach to studying epilepsy has yielded a surprising discovery about what causes one form of the disease, and may help in the search for better medicines to treat all kinds of seizure disorders.
Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet medical needs, primarily for the treatment of neurodegenerative diseases, announced today top-line results from the Company's Phase 1 clinical study of NP001 for the treatment of Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease).
Alere Inc. announced today that it has been awarded a grant of up to $21.6 million and debt financing of up to $20.6 million from the Bill & Melinda Gates Foundation.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Howard W Lynd, MD 2550 Windy Hill Rd Se, Suite 215, Marietta, GA 30067-8665 Ph: (770) 850-8464 | Howard W Lynd, MD 286 Us Highway 23 N, Suite 102, Prestonsburg, KY 41653-8732 Ph: (606) 874-0032 |
News Archive
Cancer cells have an uncanny ability to evolve and adapt to overcome the treatments used against them. While patient survival has been extended by modern drugs that block the production or action of male hormones that fuel prostate cancer - androgen receptor inhibitors such as enzalutamide, apalutamide, darolutamide, and abiraterone - eventually these drugs stop working.
Scientists at the Johns Hopkins Kimmel Cancer Center say they have preliminary evidence in laboratory-grown, human airway cells that a condensed form of cigarette smoke triggers so-called "epigenetic" changes in the cells consistent with the earliest steps toward lung cancer development.
A new stem cell-based approach to studying epilepsy has yielded a surprising discovery about what causes one form of the disease, and may help in the search for better medicines to treat all kinds of seizure disorders.
Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet medical needs, primarily for the treatment of neurodegenerative diseases, announced today top-line results from the Company's Phase 1 clinical study of NP001 for the treatment of Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease).
Alere Inc. announced today that it has been awarded a grant of up to $21.6 million and debt financing of up to $20.6 million from the Bill & Melinda Gates Foundation.
› Verified 8 days ago